APO Research
Talk to an analyst

APO RESEARCH · REPORT

Dutasteride Drug

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Dutasteride Drug Market Analysis and Forecast 2026-2032

29 December 2025204 pages

Choose your research edition.

Industry ResearchDutasteride Drug Industry Research Report 2026130 pages · $2,950 USDIndustry Growth & TrendsGlobal Dutasteride Drug Industry Growth and Trends Forecast to 2032116 pages · $3,450 USDMarket StructureGlobal Dutasteride Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Dutasteride Drug Market Outlook and Growth Opportunities 2026205 pages · $4,250 USDMarket Analysis & ForecastGlobal Dutasteride Drug Market Analysis and Forecast 2026-2032204 pages · $4,950 USD

Market perspective

The global Dutasteride Drug market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Dutasteride Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Dutasteride Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Dutasteride Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Dutasteride Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Dutasteride Drug include GSK, Acella Pharmaceuticals, Amneal Pharmaceuticals, Ascent Pharmaceuticals, Aurobindo Pharma, Barr Pharmaceuticals, Chartwell, Endo and Strides Pharma, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Dutasteride Drug, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Dutasteride Drug, also provides the sales of main regions and countries. Of the upcoming market potential for Dutasteride Drug, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Dutasteride Drug sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Dutasteride Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Dutasteride Drug sales, projected growth trends, production technology, application and end-user industry.

Dutasteride Drug Segment by Company

GSK

Acella Pharmaceuticals

Amneal Pharmaceuticals

Ascent Pharmaceuticals

Aurobindo Pharma

Barr Pharmaceuticals

Chartwell

Endo

Strides Pharma

Waylis Therapeutics

Zydus

Chengdu Suncadia Medicine

Jiangsu Wangao Pharmaceutical

Qilu Pharmaceutical

Humanwell Puracap

Sichuan Gowell Pharmaceutical

Dutasteride Drug Segment by Type

Single Drug

Combination Preparation

Dutasteride Drug Segment by Application

Retail Pharmacy

Hospital Pharmacy

Online Pharmacy

Dutasteride Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dutasteride Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Dutasteride Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dutasteride Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Dutasteride Drug in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Dutasteride Drug manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Dutasteride Drug sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Dutasteride Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Single Drug Major Manufacturers Table 3. Combination Preparation Major Manufacturers Table 4. Global Dutasteride Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Retail Pharmacy Major Manufacturers Table 6. Hospital Pharmacy Major Manufacturers Table 7. Online Pharmacy Major Manufacturers Table 8. Dutasteride Drug Industry Trends Table 9. Dutasteride Drug Industry Drivers Table 10. Dutasteride Drug Industry Opportunities and Challenges Table 11. Dutasteride Drug Industry Restraints Table 12. Global Dutasteride Drug Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Dutasteride Drug Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Dutasteride Drug Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Dutasteride Drug Revenue Market Share by Region (2021-2026) Table 16. Global Dutasteride Drug Revenue Market Share by Region (2027-2032) Table 17. Global Dutasteride Drug Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 18. Global Dutasteride Drug Sales by Region (2021-2026) & (K Units) Table 19. Global Dutasteride Drug Sales by Region (2027-2032) & (K Units) Table 20. Global Dutasteride Drug Sales Market Share by Region (2021-2026) Table 21. Global Dutasteride Drug Sales Market Share by Region (2027-2032) Table 22. Global Dutasteride Drug Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Dutasteride Drug Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Dutasteride Drug Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Dutasteride Drug Sales Market Share by Manufacturers (2021-2026) Table 26. Global Dutasteride Drug Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 27. Global Dutasteride Drug Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Dutasteride Drug Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Dutasteride Drug Manufacturers, Product Type & Application Table 30. Global Dutasteride Drug Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Dutasteride Drug by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Dutasteride Drug Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Dutasteride Drug Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Dutasteride Drug Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Dutasteride Drug Revenue Market Share by Type (2021-2026) Table 37. Global Dutasteride Drug Revenue Market Share by Type (2027-2032) Table 38. Global Dutasteride Drug Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 39. Global Dutasteride Drug Sales by Type (2021-2026) & (K Units) Table 40. Global Dutasteride Drug Sales by Type (2027-2032) & (K Units) Table 41. Global Dutasteride Drug Sales Market Share by Type (2021-2026) Table 42. Global Dutasteride Drug Sales Market Share by Type (2027-2032) Table 43. Global Dutasteride Drug Price by Type (2021-2026) & (US$/Unit) Table 44. Global Dutasteride Drug Price by Type (2027-2032) & (US$/Unit) Table 45. Global Dutasteride Drug Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Dutasteride Drug Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Dutasteride Drug Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Dutasteride Drug Revenue Market Share by Application (2021-2026) Table 49. Global Dutasteride Drug Revenue Market Share by Application (2027-2032) Table 50. Global Dutasteride Drug Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 51. Global Dutasteride Drug Sales by Application (2021-2026) & (K Units) Table 52. Global Dutasteride Drug Sales by Application (2027-2032) & (K Units) Table 53. Global Dutasteride Drug Sales Market Share by Application (2021-2026) Table 54. Global Dutasteride Drug Sales Market Share by Application (2027-2032) Table 55. Global Dutasteride Drug Price by Application (2021-2026) & (US$/Unit) Table 56. Global Dutasteride Drug Price by Application (2027-2032) & (US$/Unit) Table 57. GSK Company Information Table 58. GSK Business Overview Table 59. GSK Dutasteride Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 60. GSK Dutasteride Drug Product Portfolio Table 61. GSK Recent Development Table 62. Acella Pharmaceuticals Company Information Table 63. Acella Pharmaceuticals Business Overview Table 64. Acella Pharmaceuticals Dutasteride Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 65. Acella Pharmaceuticals Dutasteride Drug Product Portfolio Table 66. Acella Pharmaceuticals Recent Development Table 67. Amneal Pharmaceuticals Company Information Table 68. Amneal Pharmaceuticals Business Overview Table 69. Amneal Pharmaceuticals Dutasteride Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. Amneal Pharmaceuticals Dutasteride Drug Product Portfolio Table 71. Amneal Pharmaceuticals Recent Development Table 72. Ascent Pharmaceuticals Company Information Table 73. Ascent Pharmaceuticals Business Overview Table 74. Ascent Pharmaceuticals Dutasteride Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Ascent Pharmaceuticals Dutasteride Drug Product Portfolio Table 76. Ascent Pharmaceuticals Recent Development Table 77. Aurobindo Pharma Company Information Table 78. Aurobindo Pharma Business Overview Table 79. Aurobindo Pharma Dutasteride Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Aurobindo Pharma Dutasteride Drug Product Portfolio Table 81. Aurobindo Pharma Recent Development Table 82. Barr Pharmaceuticals Company Information Table 83. Barr Pharmaceuticals Business Overview Table 84. Barr Pharmaceuticals Dutasteride Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Barr Pharmaceuticals Dutasteride Drug Product Portfolio Table 86. Barr Pharmaceuticals Recent Development Table 87. Chartwell Company Information Table 88. Chartwell Business Overview Table 89. Chartwell Dutasteride Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Chartwell Dutasteride Drug Product Portfolio Table 91. Chartwell Recent Development Table 92. Endo Company Information Table 93. Endo Business Overview Table 94. Endo Dutasteride Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Endo Dutasteride Drug Product Portfolio Table 96. Endo Recent Development Table 97. Strides Pharma Company Information Table 98. Strides Pharma Business Overview Table 99. Strides Pharma Dutasteride Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Strides Pharma Dutasteride Drug Product Portfolio Table 101. Strides Pharma Recent Development Table 102. Waylis Therapeutics Company Information Table 103. Waylis Therapeutics Business Overview Table 104. Waylis Therapeutics Dutasteride Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Waylis Therapeutics Dutasteride Drug Product Portfolio Table 106. Waylis Therapeutics Recent Development Table 107. Zydus Company Information Table 108. Zydus Business Overview Table 109. Zydus Dutasteride Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Zydus Dutasteride Drug Product Portfolio Table 111. Zydus Recent Development Table 112. Chengdu Suncadia Medicine Company Information Table 113. Chengdu Suncadia Medicine Business Overview Table 114. Chengdu Suncadia Medicine Dutasteride Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Chengdu Suncadia Medicine Dutasteride Drug Product Portfolio Table 116. Chengdu Suncadia Medicine Recent Development Table 117. Jiangsu Wangao Pharmaceutical Company Information Table 118. Jiangsu Wangao Pharmaceutical Business Overview Table 119. Jiangsu Wangao Pharmaceutical Dutasteride Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. Jiangsu Wangao Pharmaceutical Dutasteride Drug Product Portfolio Table 121. Jiangsu Wangao Pharmaceutical Recent Development Table 122. Qilu Pharmaceutical Company Information Table 123. Qilu Pharmaceutical Business Overview Table 124. Qilu Pharmaceutical Dutasteride Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 125. Qilu Pharmaceutical Dutasteride Drug Product Portfolio Table 126. Qilu Pharmaceutical Recent Development Table 127. Humanwell Puracap Company Information Table 128. Humanwell Puracap Business Overview Table 129. Humanwell Puracap Dutasteride Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 130. Humanwell Puracap Dutasteride Drug Product Portfolio Table 131. Humanwell Puracap Recent Development Table 132. Sichuan Gowell Pharmaceutical Company Information Table 133. Sichuan Gowell Pharmaceutical Business Overview Table 134. Sichuan Gowell Pharmaceutical Dutasteride Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 135. Sichuan Gowell Pharmaceutical Dutasteride Drug Product Portfolio Table 136. Sichuan Gowell Pharmaceutical Recent Development Table 137. North America Dutasteride Drug Revenue by Type (2021-2026) & (US$ Million) Table 138. North America Dutasteride Drug Revenue by Type (2027-2032) & (US$ Million) Table 139. North America Dutasteride Drug Sales by Type (2021-2026) & (K Units) Table 140. North America Dutasteride Drug Sales by Type (2027-2032) & (K Units) Table 141. North America Dutasteride Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 142. North America Dutasteride Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 143. North America Dutasteride Drug Revenue by Application (2021-2026) & (US$ Million) Table 144. North America Dutasteride Drug Revenue by Application (2027-2032) & (US$ Million) Table 145. North America Dutasteride Drug Sales by Application (2021-2026) & (K Units) Table 146. North America Dutasteride Drug Sales by Application (2027-2032) & (K Units) Table 147. North America Dutasteride Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 148. North America Dutasteride Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 149. North America Dutasteride Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 150. North America Dutasteride Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 151. North America Dutasteride Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 152. North America Dutasteride Drug Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 153. North America Dutasteride Drug Sales by Country (2021-2026) & (K Units) Table 154. North America Dutasteride Drug Sales by Country (2027-2032) & (K Units) Table 155. North America Dutasteride Drug Sales Price by Country (2021-2026) & (US$/Unit) Table 156. North America Dutasteride Drug Sales Price by Country (2027-2032) & (US$/Unit) Table 157. United States Dutasteride Drug Revenue (2021-2032) & (US$ Million) Table 158. Canada Dutasteride Drug Revenue (2021-2032) & (US$ Million) Table 159. Mexico Dutasteride Drug Revenue (2021-2032) & (US$ Million) Table 160. Europe Dutasteride Drug Revenue by Type (2021-2026) & (US$ Million) Table 161. Europe Dutasteride Drug Revenue by Type (2027-2032) & (US$ Million) Table 162. Europe Dutasteride Drug Sales by Type (2021-2026) & (K Units) Table 163. Europe Dutasteride Drug Sales by Type (2027-2032) & (K Units) Table 164. Europe Dutasteride Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 165. Europe Dutasteride Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 166. Europe Dutasteride Drug Revenue by Application (2021-2026) & (US$ Million) Table 167. Europe Dutasteride Drug Revenue by Application (2027-2032) & (US$ Million) Table 168. Europe Dutasteride Drug Sales by Application (2021-2026) & (K Units) Table 169. Europe Dutasteride Drug Sales by Application (2027-2032) & (K Units) Table 170. Europe Dutasteride Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 171. Europe Dutasteride Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 172. Europe Dutasteride Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 173. Europe Dutasteride Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 174. Europe Dutasteride Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 175. Europe Dutasteride Drug Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 176. Europe Dutasteride Drug Sales by Country (2021-2026) & (K Units) Table 177. Europe Dutasteride Drug Sales by Country (2027-2032) & (K Units) Table 178. Europe Dutasteride Drug Sales Price by Country (2021-2026) & (US$/Unit) Table 179. Europe Dutasteride Drug Sales Price by Country (2027-2032) & (US$/Unit) Table 180. Germany Dutasteride Drug Revenue (2021-2032) & (US$ Million) Table 181. France Dutasteride Drug Revenue (2021-2032) & (US$ Million) Table 182. U.K. Dutasteride Drug Revenue (2021-2032) & (US$ Million) Table 183. Italy Dutasteride Drug Revenue (2021-2032) & (US$ Million) Table 184. Russia Dutasteride Drug Revenue (2021-2032) & (US$ Million) Table 185. Spain Dutasteride Drug Revenue (2021-2032) & (US$ Million) Table 186. Netherlands Dutasteride Drug Revenue (2021-2032) & (US$ Million) Table 187. Switzerland Dutasteride Drug Revenue (2021-2032) & (US$ Million) Table 188. Sweden Dutasteride Drug Revenue (2021-2032) & (US$ Million) Table 189. Poland Dutasteride Drug Revenue (2021-2032) & (US$ Million) Table 190. China Dutasteride Drug Revenue by Type (2021-2026) & (US$ Million) Table 191. China Dutasteride Drug Revenue by Type (2027-2032) & (US$ Million) Table 192. China Dutasteride Drug Sales by Type (2021-2026) & (K Units) Table 193. China Dutasteride Drug Sales by Type (2027-2032) & (K Units) Table 194. China Dutasteride Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 195. China Dutasteride Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 196. China Dutasteride Drug Revenue by Application (2021-2026) & (US$ Million) Table 197. China Dutasteride Drug Revenue by Application (2027-2032) & (US$ Million) Table 198. China Dutasteride Drug Sales by Application (2021-2026) & (K Units) Table 199. China Dutasteride Drug Sales by Application (2027-2032) & (K Units) Table 200. China Dutasteride Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 201. China Dutasteride Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 202. Asia Dutasteride Drug Revenue by Type (2021-2026) & (US$ Million) Table 203. Asia Dutasteride Drug Revenue by Type (2027-2032) & (US$ Million) Table 204. Asia Dutasteride Drug Sales by Type (2021-2026) & (K Units) Table 205. Asia Dutasteride Drug Sales by Type (2027-2032) & (K Units) Table 206. Asia Dutasteride Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 207. Asia Dutasteride Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 208. Asia Dutasteride Drug Revenue by Application (2021-2026) & (US$ Million) Table 209. Asia Dutasteride Drug Revenue by Application (2027-2032) & (US$ Million) Table 210. Asia Dutasteride Drug Sales by Application (2021-2026) & (K Units) Table 211. Asia Dutasteride Drug Sales by Application (2027-2032) & (K Units) Table 212. Asia Dutasteride Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 213. Asia Dutasteride Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 214. Asia Dutasteride Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 215. Asia Dutasteride Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 216. Asia Dutasteride Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 217. Asia Dutasteride Drug Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 218. Asia Dutasteride Drug Sales by Country (2021-2026) & (K Units) Table 219. Asia Dutasteride Drug Sales by Country (2027-2032) & (K Units) Table 220. Asia Dutasteride Drug Sales Price by Country (2021-2026) & (US$/Unit) Table 221. Asia Dutasteride Drug Sales Price by Country (2027-2032) & (US$/Unit) Table 222. Japan Dutasteride Drug Revenue (2021-2032) & (US$ Million) Table 223. South Korea Dutasteride Drug Revenue (2021-2032) & (US$ Million) Table 224. India Dutasteride Drug Revenue (2021-2032) & (US$ Million) Table 225. Australia Dutasteride Drug Revenue (2021-2032) & (US$ Million) Table 226. Taiwan Dutasteride Drug Revenue (2021-2032) & (US$ Million) Table 227. Southeast Asia Dutasteride Drug Revenue (2021-2032) & (US$ Million) Table 228. SAMEA Dutasteride Drug Revenue by Type (2021-2026) & (US$ Million) Table 229. SAMEA Dutasteride Drug Revenue by Type (2027-2032) & (US$ Million) Table 230. SAMEA Dutasteride Drug Sales by Type (2021-2026) & (K Units) Table 231. SAMEA Dutasteride Drug Sales by Type (2027-2032) & (K Units) Table 232. SAMEA Dutasteride Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 233. SAMEA Dutasteride Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 234. SAMEA Dutasteride Drug Revenue by Application (2021-2026) & (US$ Million) Table 235. SAMEA Dutasteride Drug Revenue by Application (2027-2032) & (US$ Million) Table 236. SAMEA Dutasteride Drug Sales by Application (2021-2026) & (K Units) Table 237. SAMEA Dutasteride Drug Sales by Application (2027-2032) & (K Units) Table 238. SAMEA Dutasteride Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 239. SAMEA Dutasteride Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 240. SAMEA Dutasteride Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 241. SAMEA Dutasteride Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 242. SAMEA Dutasteride Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 243. SAMEA Dutasteride Drug Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 244. SAMEA Dutasteride Drug Sales by Country (2021-2026) & (K Units) Table 245. SAMEA Dutasteride Drug Sales by Country (2027-2032) & (K Units) Table 246. SAMEA Dutasteride Drug Sales Price by Country (2021-2026) & (US$/Unit) Table 247. SAMEA Dutasteride Drug Sales Price by Country (2027-2032) & (US$/Unit) Table 248. Brazil Dutasteride Drug Revenue (2021-2032) & (US$ Million) Table 249. Argentina Dutasteride Drug Revenue (2021-2032) & (US$ Million) Table 250. Chile Dutasteride Drug Revenue (2021-2032) & (US$ Million) Table 251. Colombia Dutasteride Drug Revenue (2021-2032) & (US$ Million) Table 252. Peru Dutasteride Drug Revenue (2021-2032) & (US$ Million) Table 253. Saudi Arabia Dutasteride Drug Revenue (2021-2032) & (US$ Million) Table 254. Israel Dutasteride Drug Revenue (2021-2032) & (US$ Million) Table 255. UAE Dutasteride Drug Revenue (2021-2032) & (US$ Million) Table 256. Turkey Dutasteride Drug Revenue (2021-2032) & (US$ Million) Table 257. Iran Dutasteride Drug Revenue (2021-2032) & (US$ Million) Table 258. Egypt Dutasteride Drug Revenue (2021-2032) & (US$ Million) Table 259. Key Raw Materials Table 260. Raw Materials Key Suppliers Table 261. Dutasteride Drug Distributors List Table 262. Dutasteride Drug Customers List Table 263. Research Programs/Design for This Report Table 264. Authors List of This Report Table 265. Secondary Sources Table 266. Primary Sources List of Figures Figure 1. Dutasteride Drug Image Figure 2. Global Dutasteride Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Dutasteride Drug Market Size Share 2021 VS 2025 VS 2032 Figure 4. Single Drug Image Figure 5. Combination Preparation Image Figure 6. Global Dutasteride Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Dutasteride Drug Market Size Share 2021 VS 2025 VS 2032 Figure 8. Retail Pharmacy Image Figure 9. Hospital Pharmacy Image Figure 10. Online Pharmacy Image Figure 11. Global Dutasteride Drug Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Dutasteride Drug Revenue (2021-2032) & (US$ Million) Figure 13. Global Dutasteride Drug Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Dutasteride Drug Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Dutasteride Drug Revenue Market Share by Region (2021-2032) Figure 16. Global Dutasteride Drug Sales (2021-2032) & (K Units) Figure 17. Global Dutasteride Drug Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 18. Global Dutasteride Drug Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Dutasteride Drug Sales YoY (2021-2032) & (K Units) Figure 20. Europe Dutasteride Drug Sales YoY (2021-2032) & (K Units) Figure 21. China Dutasteride Drug Sales YoY (2021-2032) & (K Units) Figure 22. Asia (Excluding China) Dutasteride Drug Sales YoY (2021-2032) & (K Units) Figure 23. South America, Middle East and Africa Dutasteride Drug Sales YoY (2021-2032) & (K Units) Figure 24. Global Dutasteride Drug Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Dutasteride Drug Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Dutasteride Drug Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Dutasteride Drug Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Dutasteride Drug Revenue Market Share by Type (2021-2032) Figure 30. Global Dutasteride Drug Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 31. Global Dutasteride Drug Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Dutasteride Drug Sales Market Share by Type (2021-2032) Figure 33. Global Dutasteride Drug Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Dutasteride Drug Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Dutasteride Drug Revenue Market Share by Application (2021-2032) Figure 36. Global Dutasteride Drug Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 37. Global Dutasteride Drug Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Dutasteride Drug Sales Market Share by Application (2021-2032) Figure 39. North America Dutasteride Drug Revenue Share by Type (2021-2032) Figure 40. North America Dutasteride Drug Sales Share by Type (2021-2032) Figure 41. North America Dutasteride Drug Revenue Share by Application (2021-2032) Figure 42. North America Dutasteride Drug Sales Share by Application (2021-2032) Figure 43. North America Dutasteride Drug Revenue Share by Country (2021-2032) Figure 44. North America Dutasteride Drug Sales Share by Country (2021-2032) Figure 45. Europe Dutasteride Drug Revenue Share by Type (2021-2032) Figure 46. Europe Dutasteride Drug Sales Share by Type (2021-2032) Figure 47. Europe Dutasteride Drug Revenue Share by Application (2021-2032) Figure 48. Europe Dutasteride Drug Sales Share by Application (2021-2032) Figure 49. Europe Dutasteride Drug Revenue Share by Country (2021-2032) Figure 50. Europe Dutasteride Drug Sales Share by Country (2021-2032) Figure 51. China Dutasteride Drug Revenue Share by Type (2021-2032) Figure 52. China Dutasteride Drug Sales Share by Type (2021-2032) Figure 53. China Dutasteride Drug Revenue Share by Application (2021-2032) Figure 54. China Dutasteride Drug Sales Share by Application (2021-2032) Figure 55. Asia Dutasteride Drug Revenue Share by Type (2021-2032) Figure 56. Asia Dutasteride Drug Sales Share by Type (2021-2032) Figure 57. Asia Dutasteride Drug Revenue Share by Application (2021-2032) Figure 58. Asia Dutasteride Drug Sales Share by Application (2021-2032) Figure 59. Asia Dutasteride Drug Revenue Share by Country (2021-2032) Figure 60. Asia Dutasteride Drug Sales Share by Country (2021-2032) Figure 61. SAMEA Dutasteride Drug Revenue Share by Type (2021-2032) Figure 62. SAMEA Dutasteride Drug Sales Share by Type (2021-2032) Figure 63. SAMEA Dutasteride Drug Revenue Share by Application (2021-2032) Figure 64. SAMEA Dutasteride Drug Sales Share by Application (2021-2032) Figure 65. SAMEA Dutasteride Drug Revenue Share by Country (2021-2032) Figure 66. SAMEA Dutasteride Drug Sales Share by Country (2021-2032) Figure 67. Dutasteride Drug Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Dutasteride Drug Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Single Drug
  • Combination Preparation
Applications
  • Retail Pharmacy
  • Hospital Pharmacy
  • Online Pharmacy
Companies covered
  • GSK
  • Acella Pharmaceuticals
  • Amneal Pharmaceuticals
  • Ascent Pharmaceuticals
  • Aurobindo Pharma
  • Barr Pharmaceuticals
  • Chartwell
  • Endo
  • Strides Pharma
  • Waylis Therapeutics
  • Zydus
  • Chengdu Suncadia Medicine
  • Jiangsu Wangao Pharmaceutical
  • Qilu Pharmaceutical
  • Humanwell Puracap
  • Sichuan Gowell Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Dutasteride Drug Market by Type
  3. 1.2.1 Global Dutasteride Drug Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Single Drug
  5. 1.2.3 Combination Preparation
  6. 1.3 Dutasteride Drug Market by Application
  7. 1.3.1 Global Dutasteride Drug Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Retail Pharmacy
  9. 1.3.3 Hospital Pharmacy
  10. 1.3.4 Online Pharmacy
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Dutasteride Drug Market Dynamics
  1. 2.1 Dutasteride Drug Industry Trends
  2. 2.2 Dutasteride Drug Industry Drivers
  3. 2.3 Dutasteride Drug Industry Opportunities and Challenges
  4. 2.4 Dutasteride Drug Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Dutasteride Drug Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Dutasteride Drug Revenue by Region
  3. 3.2.1 Global Dutasteride Drug Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Dutasteride Drug Revenue by Region (2021-2026)
  5. 3.2.3 Global Dutasteride Drug Revenue by Region (2027-2032)
  6. 3.2.4 Global Dutasteride Drug Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Dutasteride Drug Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Dutasteride Drug Sales by Region
  9. 3.4.1 Global Dutasteride Drug Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Dutasteride Drug Sales by Region (2021-2026)
  11. 3.4.3 Global Dutasteride Drug Sales by Region (2027-2032)
  12. 3.4.4 Global Dutasteride Drug Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Dutasteride Drug Revenue by Manufacturers
  2. 4.1.1 Global Dutasteride Drug Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Dutasteride Drug Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Dutasteride Drug Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Dutasteride Drug Sales by Manufacturers
  6. 4.2.1 Global Dutasteride Drug Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Dutasteride Drug Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Dutasteride Drug Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Dutasteride Drug Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Dutasteride Drug Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Dutasteride Drug Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Dutasteride Drug Manufacturers, Product Type & Application
  13. 4.7 Global Dutasteride Drug Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Dutasteride Drug Market CR5 and HHI
  16. 4.8.2 2025 Dutasteride Drug Tier 1, Tier 2, and Tier 3
5 Dutasteride Drug Market by Type
  1. 5.1 Global Dutasteride Drug Revenue by Type
  2. 5.1.1 Global Dutasteride Drug Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Dutasteride Drug Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Dutasteride Drug Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Dutasteride Drug Sales by Type
  6. 5.2.1 Global Dutasteride Drug Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Dutasteride Drug Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Dutasteride Drug Sales Market Share by Type (2021-2032)
  9. 5.3 Global Dutasteride Drug Price by Type
6 Dutasteride Drug Market by Application
  1. 6.1 Global Dutasteride Drug Revenue by Application
  2. 6.1.1 Global Dutasteride Drug Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Dutasteride Drug Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Dutasteride Drug Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Dutasteride Drug Sales by Application
  6. 6.2.1 Global Dutasteride Drug Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Dutasteride Drug Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Dutasteride Drug Sales Market Share by Application (2021-2032)
  9. 6.3 Global Dutasteride Drug Price by Application
7 Company Profiles
  1. 7.1 GSK
  2. 7.1.1 GSK Company Information
  3. 7.1.2 GSK Business Overview
  4. 7.1.3 GSK Dutasteride Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 GSK Dutasteride Drug Product Portfolio
  6. 7.1.5 GSK Recent Developments
  7. 7.2 Acella Pharmaceuticals
  8. 7.2.1 Acella Pharmaceuticals Company Information
  9. 7.2.2 Acella Pharmaceuticals Business Overview
  10. 7.2.3 Acella Pharmaceuticals Dutasteride Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Acella Pharmaceuticals Dutasteride Drug Product Portfolio
  12. 7.2.5 Acella Pharmaceuticals Recent Developments
  13. 7.3 Amneal Pharmaceuticals
  14. 7.3.1 Amneal Pharmaceuticals Company Information
  15. 7.3.2 Amneal Pharmaceuticals Business Overview
  16. 7.3.3 Amneal Pharmaceuticals Dutasteride Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Amneal Pharmaceuticals Dutasteride Drug Product Portfolio
  18. 7.3.5 Amneal Pharmaceuticals Recent Developments
  19. 7.4 Ascent Pharmaceuticals
  20. 7.4.1 Ascent Pharmaceuticals Company Information
  21. 7.4.2 Ascent Pharmaceuticals Business Overview
  22. 7.4.3 Ascent Pharmaceuticals Dutasteride Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Ascent Pharmaceuticals Dutasteride Drug Product Portfolio
  24. 7.4.5 Ascent Pharmaceuticals Recent Developments
  25. 7.5 Aurobindo Pharma
  26. 7.5.1 Aurobindo Pharma Company Information
  27. 7.5.2 Aurobindo Pharma Business Overview
  28. 7.5.3 Aurobindo Pharma Dutasteride Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Aurobindo Pharma Dutasteride Drug Product Portfolio
  30. 7.5.5 Aurobindo Pharma Recent Developments
  31. 7.6 Barr Pharmaceuticals
  32. 7.6.1 Barr Pharmaceuticals Company Information
  33. 7.6.2 Barr Pharmaceuticals Business Overview
  34. 7.6.3 Barr Pharmaceuticals Dutasteride Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Barr Pharmaceuticals Dutasteride Drug Product Portfolio
  36. 7.6.5 Barr Pharmaceuticals Recent Developments
  37. 7.7 Chartwell
  38. 7.7.1 Chartwell Company Information
  39. 7.7.2 Chartwell Business Overview
  40. 7.7.3 Chartwell Dutasteride Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Chartwell Dutasteride Drug Product Portfolio
  42. 7.7.5 Chartwell Recent Developments
  43. 7.8 Endo
  44. 7.8.1 Endo Company Information
  45. 7.8.2 Endo Business Overview
  46. 7.8.3 Endo Dutasteride Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Endo Dutasteride Drug Product Portfolio
  48. 7.8.5 Endo Recent Developments
  49. 7.9 Strides Pharma
  50. 7.9.1 Strides Pharma Company Information
  51. 7.9.2 Strides Pharma Business Overview
  52. 7.9.3 Strides Pharma Dutasteride Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Strides Pharma Dutasteride Drug Product Portfolio
  54. 7.9.5 Strides Pharma Recent Developments
  55. 7.10 Waylis Therapeutics
  56. 7.10.1 Waylis Therapeutics Company Information
  57. 7.10.2 Waylis Therapeutics Business Overview
  58. 7.10.3 Waylis Therapeutics Dutasteride Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Waylis Therapeutics Dutasteride Drug Product Portfolio
  60. 7.10.5 Waylis Therapeutics Recent Developments
  61. 7.11 Zydus
  62. 7.11.1 Zydus Company Information
  63. 7.11.2 Zydus Business Overview
  64. 7.11.3 Zydus Dutasteride Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Zydus Dutasteride Drug Product Portfolio
  66. 7.11.5 Zydus Recent Developments
  67. 7.12 Chengdu Suncadia Medicine
  68. 7.12.1 Chengdu Suncadia Medicine Company Information
  69. 7.12.2 Chengdu Suncadia Medicine Business Overview
  70. 7.12.3 Chengdu Suncadia Medicine Dutasteride Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Chengdu Suncadia Medicine Dutasteride Drug Product Portfolio
  72. 7.12.5 Chengdu Suncadia Medicine Recent Developments
  73. 7.13 Jiangsu Wangao Pharmaceutical
  74. 7.13.1 Jiangsu Wangao Pharmaceutical Company Information
  75. 7.13.2 Jiangsu Wangao Pharmaceutical Business Overview
  76. 7.13.3 Jiangsu Wangao Pharmaceutical Dutasteride Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Jiangsu Wangao Pharmaceutical Dutasteride Drug Product Portfolio
  78. 7.13.5 Jiangsu Wangao Pharmaceutical Recent Developments
  79. 7.14 Qilu Pharmaceutical
  80. 7.14.1 Qilu Pharmaceutical Company Information
  81. 7.14.2 Qilu Pharmaceutical Business Overview
  82. 7.14.3 Qilu Pharmaceutical Dutasteride Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Qilu Pharmaceutical Dutasteride Drug Product Portfolio
  84. 7.14.5 Qilu Pharmaceutical Recent Developments
  85. 7.15 Humanwell Puracap
  86. 7.15.1 Humanwell Puracap Company Information
  87. 7.15.2 Humanwell Puracap Business Overview
  88. 7.15.3 Humanwell Puracap Dutasteride Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Humanwell Puracap Dutasteride Drug Product Portfolio
  90. 7.15.5 Humanwell Puracap Recent Developments
  91. 7.16 Sichuan Gowell Pharmaceutical
  92. 7.16.1 Sichuan Gowell Pharmaceutical Company Information
  93. 7.16.2 Sichuan Gowell Pharmaceutical Business Overview
  94. 7.16.3 Sichuan Gowell Pharmaceutical Dutasteride Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 Sichuan Gowell Pharmaceutical Dutasteride Drug Product Portfolio
  96. 7.16.5 Sichuan Gowell Pharmaceutical Recent Developments
8 North America
  1. 8.1 North America Dutasteride Drug Market Size by Type
  2. 8.1.1 North America Dutasteride Drug Revenue by Type (2021-2032)
  3. 8.1.2 North America Dutasteride Drug Sales by Type (2021-2032)
  4. 8.1.3 North America Dutasteride Drug Price by Type (2021-2032)
  5. 8.2 North America Dutasteride Drug Market Size by Application
  6. 8.2.1 North America Dutasteride Drug Revenue by Application (2021-2032)
  7. 8.2.2 North America Dutasteride Drug Sales by Application (2021-2032)
  8. 8.2.3 North America Dutasteride Drug Price by Application (2021-2032)
  9. 8.3 North America Dutasteride Drug Market Size by Country
  10. 8.3.1 North America Dutasteride Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Dutasteride Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Dutasteride Drug Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Dutasteride Drug Market Size by Type
  2. 9.1.1 Europe Dutasteride Drug Revenue by Type (2021-2032)
  3. 9.1.2 Europe Dutasteride Drug Sales by Type (2021-2032)
  4. 9.1.3 Europe Dutasteride Drug Price by Type (2021-2032)
  5. 9.2 Europe Dutasteride Drug Market Size by Application
  6. 9.2.1 Europe Dutasteride Drug Revenue by Application (2021-2032)
  7. 9.2.2 Europe Dutasteride Drug Sales by Application (2021-2032)
  8. 9.2.3 Europe Dutasteride Drug Price by Application (2021-2032)
  9. 9.3 Europe Dutasteride Drug Market Size by Country
  10. 9.3.1 Europe Dutasteride Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Dutasteride Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Dutasteride Drug Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Dutasteride Drug Market Size by Type
  2. 10.1.1 China Dutasteride Drug Revenue by Type (2021-2032)
  3. 10.1.2 China Dutasteride Drug Sales by Type (2021-2032)
  4. 10.1.3 China Dutasteride Drug Price by Type (2021-2032)
  5. 10.2 China Dutasteride Drug Market Size by Application
  6. 10.2.1 China Dutasteride Drug Revenue by Application (2021-2032)
  7. 10.2.2 China Dutasteride Drug Sales by Application (2021-2032)
  8. 10.2.3 China Dutasteride Drug Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Dutasteride Drug Market Size by Type
  2. 11.1.1 Asia Dutasteride Drug Revenue by Type (2021-2032)
  3. 11.1.2 Asia Dutasteride Drug Sales by Type (2021-2032)
  4. 11.1.3 Asia Dutasteride Drug Price by Type (2021-2032)
  5. 11.2 Asia Dutasteride Drug Market Size by Application
  6. 11.2.1 Asia Dutasteride Drug Revenue by Application (2021-2032)
  7. 11.2.2 Asia Dutasteride Drug Sales by Application (2021-2032)
  8. 11.2.3 Asia Dutasteride Drug Price by Application (2021-2032)
  9. 11.3 Asia Dutasteride Drug Market Size by Country
  10. 11.3.1 Asia Dutasteride Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Dutasteride Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Dutasteride Drug Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Dutasteride Drug Market Size by Type
  2. 12.1.1 SAMEA Dutasteride Drug Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Dutasteride Drug Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Dutasteride Drug Price by Type (2021-2032)
  5. 12.2 SAMEA Dutasteride Drug Market Size by Application
  6. 12.2.1 SAMEA Dutasteride Drug Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Dutasteride Drug Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Dutasteride Drug Price by Application (2021-2032)
  9. 12.3 SAMEA Dutasteride Drug Market Size by Country
  10. 12.3.1 SAMEA Dutasteride Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Dutasteride Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Dutasteride Drug Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Dutasteride Drug Value Chain Analysis
  2. 13.1.1 Dutasteride Drug Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Dutasteride Drug Production Mode & Process
  6. 13.2 Dutasteride Drug Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Dutasteride Drug Distributors
  9. 13.2.3 Dutasteride Drug Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst